OAR 836-200-0500: Purpose and Statutory Authority

Edition: Current OARD snapshotEffective: 2025-04-01Last verified: 2026-09-07

The purpose of OAR 836-200-0500 to 836-200-0560 is to administer the Oregon Prescription Drug Price Transparency Program established in the Department of Consumer and Business Services for the purposes of providing notice and disclosure of information relating to the cost and pricing of prescription drugs in order to provide accountability for prescription drug pricing.

Official history and status

Statutory/Other Authority: ORS 646A.689

Statutes/Other Implemented: ORS 646A.689 & 646A.692

History: ID 2-2025, amend filed 03/26/2025, effective 04/01/2025 ID 2-2019, adopt filed 02/26/2019, effective 03/01/2019

This rule cites

OAR 836-200-0500 — resolved
836-200-0560 — resolved

Cited by

OAR 836-200-0505: Definitions
OAR 836-200-0555: Assessments Against Prescription Drug Manufacturers for 2023 and prior
OAR 836-200-0560: Civil Penalties

Official source: https://secure.sos.state.or.us/oard/